FR3097560B1 - Méthode de diagnostic d’une exposition chronique à la pollution - Google Patents

Méthode de diagnostic d’une exposition chronique à la pollution Download PDF

Info

Publication number
FR3097560B1
FR3097560B1 FR1906829A FR1906829A FR3097560B1 FR 3097560 B1 FR3097560 B1 FR 3097560B1 FR 1906829 A FR1906829 A FR 1906829A FR 1906829 A FR1906829 A FR 1906829A FR 3097560 B1 FR3097560 B1 FR 3097560B1
Authority
FR
France
Prior art keywords
subject
pollution
chronic exposure
diagnosing chronic
corynebacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1906829A
Other languages
English (en)
Other versions
FR3097560A1 (fr
Inventor
Cecile Clavaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1906829A priority Critical patent/FR3097560B1/fr
Priority to CN202080045680.2A priority patent/CN114008216B/zh
Priority to EP20733834.4A priority patent/EP3987065A1/fr
Priority to US17/621,295 priority patent/US20220356511A1/en
Priority to PCT/EP2020/067712 priority patent/WO2020260396A1/fr
Publication of FR3097560A1 publication Critical patent/FR3097560A1/fr
Application granted granted Critical
Publication of FR3097560B1 publication Critical patent/FR3097560B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Méthode de diagnostic d’une exposition chronique à la pollution La présente invention a ainsi pour objet une méthode, en particulier in vitro, de diagnostic d’une exposition chronique d’un sujet, en particulier de la peau d’un sujet, à la pollution, comprenant une étape (a) de détermination, dans un échantillon de peau du sujet, du niveau d’au moins un marqueur choisi dans le groupe constitué des bactéries des espèces Corynebacterium lipophiloflavum, Corynebacterium durum, Corynebacterium propinquum, Kytococcus sedentarius, Brevibacterium sp ., Haemophilus parainfluenzae, Actinomyces oris, Neisseria sp ., Abiotrophia defectiva, Alicycliphilus sp ., Micrococcus luteus, Caulobacter sp ., Streptococcus mitis / oralis / pneumoniae et Staphylococcus epidermidis . Figure pour l'abrégé : néant
FR1906829A 2019-06-24 2019-06-24 Méthode de diagnostic d’une exposition chronique à la pollution Active FR3097560B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1906829A FR3097560B1 (fr) 2019-06-24 2019-06-24 Méthode de diagnostic d’une exposition chronique à la pollution
CN202080045680.2A CN114008216B (zh) 2019-06-24 2020-06-24 用于诊断长期暴露于污染的方法
EP20733834.4A EP3987065A1 (fr) 2019-06-24 2020-06-24 Procédé de diagnostic de l'exposition chronique à la pollution
US17/621,295 US20220356511A1 (en) 2019-06-24 2020-06-24 Method for diagnosing chronic exposure to pollution
PCT/EP2020/067712 WO2020260396A1 (fr) 2019-06-24 2020-06-24 Procédé de diagnostic de l'exposition chronique à la pollution

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1906829A FR3097560B1 (fr) 2019-06-24 2019-06-24 Méthode de diagnostic d’une exposition chronique à la pollution
FR1906829 2019-06-24

Publications (2)

Publication Number Publication Date
FR3097560A1 FR3097560A1 (fr) 2020-12-25
FR3097560B1 true FR3097560B1 (fr) 2021-06-25

Family

ID=68733153

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1906829A Active FR3097560B1 (fr) 2019-06-24 2019-06-24 Méthode de diagnostic d’une exposition chronique à la pollution

Country Status (5)

Country Link
US (1) US20220356511A1 (fr)
EP (1) EP3987065A1 (fr)
CN (1) CN114008216B (fr)
FR (1) FR3097560B1 (fr)
WO (1) WO2020260396A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115851550B (zh) * 2022-12-27 2025-01-28 广东省科学院微生物研究所(广东省微生物分析检测中心) 一种具有高分子量芳香烃类化合物降解功能的嗜脂环物菌t452及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516702C2 (de) * 1995-05-06 1999-08-19 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Substanzen
AU2003257470A1 (en) * 2002-07-18 2004-02-09 Henkel Kommanditgesellschaft Auf Aktien Detection of microorganisms
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
EP2917371A4 (fr) * 2012-11-09 2016-10-12 Univ California Procédés de pronostic de l'âge et agents d'identification qui induisent ou inhibent le vieillissement prématuré
WO2015013465A2 (fr) * 2013-07-25 2015-01-29 Dch Molecular Diagnostics, Inc. Méthodes et compositions de détection d'une contamination bactérienne
CN104372072A (zh) * 2014-07-29 2015-02-25 中国科学院苏州生物医学工程技术研究所 一种通用型检测血小板细菌污染的荧光定量pcr方法
US9833393B2 (en) * 2015-09-24 2017-12-05 Elc Management Llc Method and compositions for treating skin

Also Published As

Publication number Publication date
WO2020260396A1 (fr) 2020-12-30
FR3097560A1 (fr) 2020-12-25
EP3987065A1 (fr) 2022-04-27
US20220356511A1 (en) 2022-11-10
CN114008216A (zh) 2022-02-01
CN114008216B (zh) 2024-12-27

Similar Documents

Publication Publication Date Title
Tsuji et al. Community-and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents
Carfora et al. Enterotoxin genes, enterotoxin production, and methicillin resistance in Staphylococcus aureus isolated from milk and dairy products in Central Italy
Sola et al. Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean children
Assmann et al. Identification of vancomycin interaction with Enterococcus faecalis within 30 min of interaction time using Raman spectroscopy
Harastani et al. Molecular characteristics of Staphylococcus aureus isolated from a major hospital in Lebanon
EP3836967A4 (fr) Procédés et systèmes de traitement ou d'analyse d'échantillons
Sunagar et al. Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India
Hussein et al. Prevalence of methicillin-resistant Staphylococcus aureus in hospitals and community in Duhok, Kurdistan region of Iraq
Dos Santos et al. Presence of mecA-positive multidrug-resistant Staphylococcus epidermidis in bovine milk samples in Brazil
El-Mahdy et al. Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients
Sun et al. Biofilm formation in erythromycin-resistant Staphylococcus aureus and the relationship with antimicrobial susceptibility and molecular characteristics
RU2010142176A (ru) Способы и системы для создания кормовых композиций
Levy et al. Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine
Sinlapasorn et al. SCC mec IX in meticillin-resistant Staphylococcus aureus and meticillin-resistant coagulase-negative staphylococci from pigs and workers at pig farms in Khon Kaen, Thailand
Mshana et al. Prevalence of clindamycin inducible resistance among methicillin-resistant Staphylococcus aureus at Bugando Medical Centre, Mwanza, Tanzania
FR3097560B1 (fr) Méthode de diagnostic d’une exposition chronique à la pollution
Mongkolrattanothai et al. Simultaneous carriage of multiple genotypes of Staphylococcus aureus in children
Teo et al. ST22 and ST239 MRSA duopoly in Singaporean hospitals: 2006–2010
Rieux et al. Recent range expansion and agricultural landscape heterogeneity have only minimal effect on the spatial genetic structure of the plant pathogenic fungus Mycosphaerella fijiensis
Garcia de Carvalho et al. Resazurin microtiter assay for clarithromycin susceptibility testing of clinical isolates of Mycobacterium abscessus group
EP4257617A4 (fr) Protéine de liaison à l'antigène ciblant cd70 et son utilisation
Gallardo-Garcia et al. Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case–control study
Tian et al. PCR-dipstick DNA chromatography for profiling of a subgroup of cariesassociated bacterial species in plaque from healthy coronal surfaces and periodontal pockets
Sueke et al. lukSF-PV in Staphylococcus aureus keratitis isolates and association with clinical outcome
Yeh et al. Molecular characteristics of disease-causing and commensal Staphylococcus lugdunensis isolates from 2003 to 2013 at a tertiary hospital in Taiwan

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20201225

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8